The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn's Disease Patients with Adalimumab Non-response in the USA.

Erim, Daniel O

The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn's Disease Patients with Adalimumab Non-response in the USA. [electronic resource] - Journal of Crohn's & colitis Aug 2015 - 669-75 p. digital

Publication Type: Evaluation Study; Journal Article

1876-4479

10.1093/ecco-jcc/jjv090 doi


Adalimumab--economics
Anti-Inflammatory Agents--economics
Antibodies, Monoclonal, Humanized--economics
Computer Simulation
Crohn Disease--drug therapy
Drug Administration Schedule
Drug Costs--statistics & numerical data
Drug Therapy, Combination
Humans
Markov Chains
Models, Biological
Models, Economic
Models, Statistical
Quality of Life
Severity of Illness Index
Treatment Failure
Treatment Outcome
United States